Clinical Trials Browser

Completed × Prostatic Neoplasms × Radiation × Clear all

NCT03570827 2026-05-26

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Phase 2 Completed

53 enrolled 11 charts

Prostatic Neoplasms

NCT05230251 2025-09-12

ROADSTER

Phase 1/2 Completed

Prostatic Neoplasms

NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

Phase 2 Completed

43 enrolled 13 charts

GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT02184533 2024-05-28

Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

Phase 1 Completed

GenitourinaryPlasma cell

Multiple Myeloma, Plasmacytoma, Prostatic Neoplasms

NCT03043807 2023-02-16

A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy

Phase 2 Completed

26 enrolled 8 charts

Prostatic Neoplasms

NCT02064036 2022-10-18

CCRO025

Phase 1 Completed

Prostatic Neoplasms

NCT02716974 2022-08-04

oligo-mets

Phase 2 Completed

26 enrolled 8 charts

Prostatic Neoplasms

NCT00116142 2022-01-11

Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer

Phase 3 Completed

350 enrolled 13 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT01833208 2021-08-05

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Phase NA Completed

Prostatic Neoplasms

NCT02229734 2021-06-04

FASTR-2

Phase 2 Completed

Prostatic Neoplasms

NCT02064582 2020-10-12

Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer

Phase 2 Completed

7 enrolled 6 charts

Prostatic Neoplasms

NCT00214422 2019-07-19

Intensity Modulated Radiation Therapy for Prostate Cancer

Phase EARLY_PHASE1 Completed

19 enrolled 15 charts

Neoplasms, Prostatic Neoplasms

NCT01091883 2019-03-13

Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma

Phase NA Completed

BreastGenitourinarySarcomaThoracic

Cancer Pain, Bone Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Prostatic Neoplasms

NCT01303705 2018-08-29

Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT01641185 2017-05-04

IPI

Phase 2 Completed

Prostatic Neoplasms

NCT00033605 2016-07-13

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Phase 3 Completed

GastrointestinalGenitourinaryGynecologicSarcoma

Uterine Cervical Neoplasms, Diarrhea, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT00023686 2016-07-06

Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT01041326 2013-07-17

Preoperative Radiation Therapy for High Risk Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT00040365 2012-04-30

Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer

Phase 2 Completed

30 enrolled 13 charts

Prostatic Neoplasms